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Introduction
Previous nasal colonization is an important risk factor in
the pathogenesis of infections caused by MRSA. Moreover,
the formulation of mupirocin available in Brazil is inade-
quate for mucous membranes application, often causing
intolerable side effects.
Objectives
Evaluate the efficacy of intranasal application of silver
sulfadiazine for decolonization of hospitalized patients
carrying MRSA.
Methods
This is a double-blind randomised study conducted at a
tertiary-care university hospital, with approximately 700
beds. Adult in-patients from clinical and surgical wards
were potentially eligible to the study if they had any
Methicillin-Resistant Staphylococcus aureus isolated from
any clinical specimen on the microbiology laboratory of
the study facility. Exclusion criteria consisted of pregnant
women, age <18 years, osteomyelitis, infections with
implants and cystic fibrosis. Nasal colonization by MRSA
was confirmed by means of a nasal swab selective culture.
Patients were randomised by a pharmacist not involved on
the data collection, and submitted to application intranasal
of silver sulfadiazine 1% or placebo twice a day plus bath
with clohexidine-degermant daily for five consecutive
days. Nasal swab was repeated next day after end of
decolonization. The rate of nasal MRSA decolonization
were compared using the Fisher exact test.
Results
Twenty-five patients were included. The median time from
the day of hospitalization and inclusion in the study was
27 days (ranging from 7 to 85 days). The patient´s age
median was 55.9 years old (ranging from 19 to 89 years).
16 male and 9 female patients. From the 25 patients initi-
ally included, 20 completed the full course of the study
medication and had their cultures available after decoloni-
zation. Among the 20 patients, 5/12 (41.7%) patients in the
silver sulfadiazine and 3/8 (37.5%) of the placebo group
had negative nasal swab after decolonization (p = 0.74).
Conclusion
According to these preliminary findings, silver sulfadia-
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